Try our Advanced Search for more refined results
April 10, 2012
DEPOMED, INC. v. IMPAX LABORATORIES, INC. et al
Case Number:
3:12-cv-02154
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
April 11, 2012
Depomed Targets Impax, Par Over Generic Epilepsy Drug
Drug company Depomed Inc. on Tuesday sued Impax Laboratories Inc. and Par Pharmaceutical Cos. Inc. in New Jersey federal court, accusing the companies of making a generic version of Depomed's Gralise epilepsy medication before the patents on the drug expired.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login